GP Pharm: Injectable Products for the Urology, Oncology, CNS and CVS Fields
GP Pharm, the pharmaceutical company of the Lipotec Group, specialises in the research, development, production...
GP Pharm Looks Back on Another Successful Year at the euroPLX46
GP Pharm has successfully participated again in the 46th euroPLX edition that took place in Vienna, on 30 and 31 May 2011.
The main objective of GP Pharm during the event was to announce its product range and new projects, in order to find new partners.
The event allowed GP Pharm to conduct about 30 meetings with companies from 16 different countries. In conclusion, GP Pharm’s objective was perfectly achieved, as the company was able to progress in negotiations and monitoring of contracts ‘in place’ with some partners, as well as expanding these in some cases.
The next event where GP Pharm is going to be present is the Bio International Convention that will take place in Washington from 27 to 30 June.
All convention attendees who wish to visit us can look for booth 3237 in hall B at the Spanish Pavilion.
We will keep you informed of the results obtained on our website.
More About This Company
GP Pharm to Exhibit at CPhI 2011
For the eighth consecutive year GP Pharm will be present at CPhI, the world's most...
GP Pharm Expands its Pharmaceutical Line Against Advanced Colorectal Cancer with Oxaliplatin and Irinotecan 300mg and 500mg
GP Pharm has started the commercialisation of Oxaliplatin and Irinotecan 300mg and 500mg, drugs to...
GP Pharm Obtains Approval for GCC Countries
Last January, GCC-DR (Gulf Central Committee for Drug Registration) granted a Registration Certificate of Manufacturing...